Elisabeth Bellard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elisabeth Bellard

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

The Journal of Experimental Medicine|April 13, 2011

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptorSophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.

Plos Pathogens|July 18, 2022

Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosaKarin Santoni, David Pericat, Leana Gorse, et al.

The EMBO Journal|July 18, 2024

Ezrin, radixin, and moesin are dispensable for macrophage migration and cellular cortex mechanicsPerrine Verdys, Javier Rey Barroso, Adeline Girel, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

The Journal of Experimental Medicine|April 13, 2011

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptorSophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.

Plos Pathogens|July 18, 2022

Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosaKarin Santoni, David Pericat, Leana Gorse, et al.

The EMBO Journal|July 18, 2024

Ezrin, radixin, and moesin are dispensable for macrophage migration and cellular cortex mechanicsPerrine Verdys, Javier Rey Barroso, Adeline Girel, et al.

Pageof 5